Engineering and Development

Management and Executive

Product Management

Chief Executive Officer (CEO)

Chief Financial Officer

Tempus AI Adds Digital Pathology to Cancer Portfolio With Paige Acquisition

Genetic Testing Market to Soar to $54.2B by 2033, Driven by Personalized Medicine and Tech Innovation

Tempus AI, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. August 12, 2025 Deadline to file Lead Plaintiff Motion

mRNA Sequencing Market Size to Hit USD 4.02 billion by 2031, Growing at 13.6% CAGR, Benefits from Surging Prevalence of Cancer | The Insight Partners

Bioinformatics Scientist II

Ambry Genetics is a genetics-based healthcare company dedicated to understanding and treating human disease faster. The Bioinformatics Scientist II will analyze NGS data, develop and maintain bioinformatics pipelines, and collaborate with a cross-functional team to launch new products and improvements.

Senior Talent Acquisition Partner

Bioinformatics Scientist III

Sign up with Google

Sign in with Google